ESCMID Publications

ESCMID Panorama

Medical Guideline Publications in 2019

For a complete list of medical guideline publications in 2019, please have a look at the Publications page

Clin Microbiol Infect 2019:

Escmid-ecmm guideline: diagnosis and management of invasive aspergillosis in neonates and children.
Warris A, Lehrnbecher T, Roilides E et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30282-4. doi: 10.1016/j.cmi.2019.05.019.

Abstract

SCOPE:

Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer diagnostic tools, the pharmacology of antifungal agents and in the evidence from interventional phase III clinical trials. Therefore, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) have developed a paediatric specific guideline for the diagnosis and management of IA in neonates and children.

METHODS:

Review and discussion of the scientific literature and grading of the available quality of evidence was performed by the paediatric subgroup of the ESCMID-ECMM-European Respiratory Society (ERS) Aspergillus disease guideline working group, which was assigned the mandate for the development of neonatal and paediatric specific recommendations.

QUESTIONS:

Questions addressed by the guideline included the epidemiology of IA in neonates and children; which paediatric patients may benefit from antifungal prophylaxis; how to diagnose IA in neonates and children; which antifungal agents are available for use in neonates and children; which antifungal agents are suitable for prophylaxis and treatment of IA in neonates and children; what is the role of therapeutic drug monitoring of azole antifungals and which management strategies are suitable to be used in paediatric patients. This guideline provides recommendations for the diagnosis, prevention and treatment of IA in the paediatric population, including neonates. The aim of this guideline is to facilitate optimal management of neonates and children at risk for or diagnosed with IA.

Guideline development history:

Medical Guideline Publications before 2019

An overview of medical guidelines published before 2019 is given below

02 January 2018

Diagnosis and management of Aspergillus diseases: executive summary
of the 2017 ESCMID-ECMM-ERS guideline.

20 February 2018

Guidance document for prevention of Clostridium difficile infection in acute
healthcare settings.

01 March 2017

Surviving Sepsis Campaign:
International Guidelines for Management of Sepsis and Septic Shock

  • Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and
    Septic Shock: 2016
    . Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Intensive Care Med. 2017;43(3):304-377 and Crit Care Med. 2017 Mar;45(3):486-552.

Clin Microbiol Infect 2016; 22 (Suppl. 4)

Published guideline (published online: 22 July 2016)

This guideline was coordinated by the ESCMID Study Group for Clostridium difficile (ESGCD)

Guideline development history:

Clin Microbiol Infect 2016; 22 (Suppl. 3)

Published guideline (published online: 7 April 2016)

This guideline was coordinated by the ESCMID Study Group for Infections of the Brain (ESGIB)

Guideline development history:

Clin Microbiol Infect 2015; 21 (Suppl. 1)

Coordinated by the ESCMID Study Group for Biofilms (ESGB)

ESCMID and ECMM guidelines for the management of rare and emerging fungal infections

Clin Microbiol Infect 2014; 20 (Suppl. 3)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Editorial

O. A. Cornely et al.

Pages 1-4

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O. A. Cornely et al.

Pages 5-26

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

A. M. Tortorano et al.

Pages 27-46

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

A. Chowdhary et al.

Pages 47-75

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

M. C. Arendrup et al.

Pages 76-98

Clin Microbiol Infect 2014; Vol 20 (Suppl s2), pp 1–26

The previous European Society of Clinical Microbiology and Infection (ESCMID) guidance document, which has been applied widely in clinical practice, dates from 2009. Meanwhile, new treatments for Clostridium difficile infection (CDI) have been developed and limitations of the currently recommended treatment options of CDI are considered. As the current ESCMID treatment guidance document is already implemented in clinical practice, an update of this widely applied guidance document is essential to further improve uniformity of national hospital infection treatment policies for CDI in Europe.

Clin Microbiol Infect 2014; Vol 20 (Suppl s1), pp 1–55

Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of ‘basic’ practices, recommended for all acute care facilities, and ‘additional special approaches’ to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.

ESCMID guideline for the diagnosis and management of Candida diseases 2012

Clin Microbiol Infect 2012; 18 (Suppl. 7)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Developing European guidelines in clinical microbiology and infectious diseases

A. J. Ullmann et al.

Pages 1-8

Diagnostic procedures

M. Cuenca-Estrella et al.

Pages 9-18

Non-neutropenic adult patients

O. A. Cornely et al.

Pages 19-37

Prevention and management of invasive infections in neonates and children caused by Candida spp.

W. W. Hope et al.

Pages 38-52

Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

A. J. Ullmann et al.

Pages 53-67

Patients with HIV infection or AIDS

O. Lortholary et al.

Pages 68-77

ESCMID Sore Throat Guideline Group

C. Pelucchi, L. Grigoryan, C. Galeone, S. Esposito, P. Huovinen, P. Little and T. Verheij. Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–27

Full text

M. P. Bauer, E. J. Kuijper and J. T. van Dissel, Clin Microbiol Infect 2009; 15: 1067–1079

M. J. T. Crobach, O. M. Dekkers, M. H. Wilcox and E. J. Kuijper, Clin Microbiol Infect 2009; 15: 1053–1066

Guidelines for the validation and application of typing methods for use in bacterial epidemiology

A. van Belkum et. al on behalf of the ESCMID Study Group on Epidemiological Markers (ESGEM), Clin Micro Biol Infect 2007: 13 (Suppl. 3): 1-46

download

Guidelines for the management of adult lower respiratory tract infections

M. Woodhead et al., Eur Respir J 2005 26: 1138-1180

download

Guidelines for the management of adult lower respiratory tract infections. Appendices

M. Woodhead et al.

download

European recommendations for antimicrobial resistance surveillance

G. Cornaglia et al., ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), Clin Microbiol Infect 2004 10: 349-383

download

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe

P. Brouqui et al., ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella (ESCAR) and the European Network for Surveillance of Tick-Borne Diseases, Clin Microbiol Infect 2004 10: 1108-1132

download

A European survey of diagnostic methods and testing protocols for Clostridium dificile

Barbut et al., ESCMID Study Group on Clostridium difficile (ESGCD), Clin Microbiol Infect 2003 9: 989-996

download

Last update: 23 August 2016

Do you need funding for guideline production?

Detailed guidance is provided in the ESCMID Operating Procedures for Medical Guidelines.

EOPs for Medical Guidelines